Fund
True Ventures
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 2
- Lead
- 0
- New entries
- 2
- Follow ons
- 0
- Latest operation
- 23 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 23 Sept | United Kingdom, Biotech | Series C | 140 M$ | Participant |
| 23 Sept | United States, Biotech | Series D and later | 311 M$ | Participant |
Co investors 29 funds crossed
- Catalio Capital Management 2 operations
- Alderline Group 1 operation
- André Hoffmann, vice-président de Roche, à titre personnel 1 operation
- Anthology Fund (Anthropic) 1 operation
- Baillie Gifford 1 operation
- Digitalis Ventures 1 operation
- Dimension 1 operation
- Durable Capital Partners 1 operation
- European Tech Collective 1 operation
- Firebrand River Capital 1 operation
- FPV Ventures 1 operation
- ICONIQ 1 operation
- Inception Fund 1 operation
- King Philanthropies 1 operation
- Kinnevik 1 operation
- Lifeforce Capital 1 operation
- Lightspeed 1 operation
- Lux Capital 1 operation
- NATO Innovation Fund 1 operation
- NVIDIA 1 operation
- PostScriptum 1 operation
- Premji Invest 1 operation
- Redalpine 1 operation
- S32 1 operation
- Singular 1 operation
- Sovereign AI 1 operation
- Surveyor Capital 1 operation
- T. Rowe Price Investment Management 1 operation
- The Rockefeller Foundation 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United Kingdom, United States.